Offer - Urjas Oil for just ₹ 1
Symbiva 400 Octacap is a commercial drug that is prescribed in the form of Capsule. It is typically used for the treatment of Asthma. Other than this, Symbiva 400 Octacap has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Symbiva 400 Octacap depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Symbiva 400 Octacap include Nasopharyngitis, Headache, Back Pain. While these are the most often observed Symbiva 400 Octacap side effects, there are can be others also. These have been listed below. Normally, these side effects of Symbiva 400 Octacap are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Symbiva 400 Octacap's effect is Moderate during pregnancy and Moderate for lactating mothers. In addition, Symbiva 400 Octacap's effects on the liver, heart and kidney are discussed below in the Symbiva 400 Octacap related warnings section.
Other conditions have been mentioned below in the Symbiva 400 Octacap contraindications section.
Drug reaction of Symbiva 400 Octacap with other medicines has been reported. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Symbiva 400 Octacap is considered safe while driving, and is addictive.
Symbiva 400 Octacap is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Symbiva 400 Octacap safe for pregnant women?
Pregnant women may experience moderate side effects from Symbiva. It is best to stop taking Symbiva immediately and inform your doctor if you notice any discomfort.
Is the use of Symbiva 400 Octacap safe during breastfeeding?
Symbiva can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Symbiva 400 Octacap on the Kidneys?
There are no side effects of Symbiva on the kidneys.
What is the effect of Symbiva 400 Octacap on the Liver?
Symbiva does not damage the liver.
What is the effect of Symbiva 400 Octacap on the Heart?
Symbiva is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Symbiva 400 Octacap unless your doctor advises you to do so -
Is this Symbiva 400 Octacap habit forming or addictive?
No, you will not get addicted to Symbiva 400 Octacap.
Is it safe to drive or operate heavy machinery when consuming?
Symbiva 400 Octacap will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Symbiva 400 Octacap should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Symbiva 400 Octacap in mental disorders is not effective.
Interaction between Food and Symbiva 400 Octacap
Taking Symbiva 400 Octacap with food is safe.
Interaction between Alcohol and Symbiva 400 Octacap
Taking Symbiva 400 Octacap with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
Product Description [Internet]: SYMBICORT. AstraZeneca
